Literature DB >> 25942601

A new effect of IL-4 on human γδ T cells: promoting regulatory Vδ1 T cells via IL-10 production and inhibiting function of Vδ2 T cells.

Yujia Mao1, Shanshan Yin1, Jianmin Zhang1,2, Yu Hu1,2, Bo Huang1, Lianxian Cui1,2, Ning Kang1,2, Wei He1,2.   

Abstract

Interleukin 4 (IL-4) has a variety of immune functions, including helper T-cell (Th-cell) differentiation and innate immune-response processes. However, the impact of IL-4 on gamma delta (γδ) T cells remains unclear. In this study, we investigate the effects of IL-4 on the activation and proliferation of γδ T cells and the balance between variable delta 1 (Vδ1) and Vδ2 T cells in humans. The results show that IL-4 inhibits the activation of γδ T cells in the presence of γδ T-cell receptor (TCR) stimulation in a STAT6-dependent manner. IL-4 promoted the growth of activated γδ T cells and increased the levels of Vδ1 T cells, which in turn inhibited Vδ2 T-cell growth via significant IL-10 secretion. Vδ1 T cells secreted significantly less interferon gamma (IFNγ) and more IL-10 relative to Vδ2. Furthermore, Vδ1 T cells showed relatively low levels of Natural Killer Group 2D (NKG2D) expression in the presence of IL-4, suggesting that Vδ1 T cells weaken the γδ T cell-mediated anti-tumor immune response. For the first time, our findings demonstrate a negative regulatory role of IL-4 in γδ T cell-mediated anti-tumor immunity.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25942601      PMCID: PMC4786628          DOI: 10.1038/cmi.2015.07

Source DB:  PubMed          Journal:  Cell Mol Immunol        ISSN: 1672-7681            Impact factor:   11.530


  57 in total

Review 1.  [gamma][delta] cells: a right time and a right place for a conserved third way of protection.

Authors:  A C Hayday
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  MICA engagement by human Vgamma2Vdelta2 T cells enhances their antigen-dependent effector function.

Authors:  H Das; V Groh; C Kuijl; M Sugita; C T Morita; T Spies; J F Bukowski
Journal:  Immunity       Date:  2001-07       Impact factor: 31.745

3.  Regulation of cutaneous malignancy by gammadelta T cells.

Authors:  M Girardi; D E Oppenheim; C R Steele; J M Lewis; E Glusac; R Filler; P Hobby; B Sutton; R E Tigelaar; A C Hayday
Journal:  Science       Date:  2001-09-20       Impact factor: 47.728

4.  Experimental autoimmune encephalomyelitis on the SJL mouse: effect of gamma delta T cell depletion on chemokine and chemokine receptor expression in the central nervous system.

Authors:  A J Rajan; V C Asensio; I L Campbell; C F Brosnan
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

5.  Generation of human regulatory gammadelta T cells by TCRgammadelta stimulation in the presence of TGF-beta and their involvement in the pathogenesis of systemic lupus erythematosus.

Authors:  Xiaoyan Li; Ning Kang; Xuan Zhang; Xiaoying Dong; Wei Wei; Lianxian Cui; Denian Ba; Wei He
Journal:  J Immunol       Date:  2011-05-11       Impact factor: 5.422

6.  Interleukin 4 receptor on human lung cancer: a molecular target for cytotoxin therapy.

Authors:  Mariko Kawakami; Koji Kawakami; Vitaly A Stepensky; Richard A Maki; Howard Robin; Wayne Muller; Syed R Husain; Raj K Puri
Journal:  Clin Cancer Res       Date:  2002-11       Impact factor: 12.531

7.  Targeting interleukin-4 receptors for effective pancreatic cancer therapy.

Authors:  Koji Kawakami; Mariko Kawakami; Syed R Husain; Raj K Puri
Journal:  Cancer Res       Date:  2002-07-01       Impact factor: 12.701

8.  The functional impairment of HCC-infiltrating γδ T cells, partially mediated by regulatory T cells in a TGFβ- and IL-10-dependent manner.

Authors:  Yong Yi; Hong-Wei He; Jia-Xing Wang; Xiao-Yan Cai; Yi-Wei Li; Jian Zhou; Yun-Feng Cheng; Jian-Jun Jin; Jia Fan; Shuang-Jian Qiu
Journal:  J Hepatol       Date:  2012-12-20       Impact factor: 25.083

9.  Differentiation of human peripheral blood Vδ1+ T cells expressing the natural cytotoxicity receptor NKp30 for recognition of lymphoid leukemia cells.

Authors:  Daniel V Correia; Manuela Fogli; Kelly Hudspeth; Maria Gomes da Silva; Domenico Mavilio; Bruno Silva-Santos
Journal:  Blood       Date:  2011-06-01       Impact factor: 22.113

10.  Human breast carcinoma cells express type II IL-4 receptors and are sensitive to antitumor activity of a chimeric IL-4-Pseudomonas exotoxin fusion protein in vitro and in vivo.

Authors:  P Leland; J Taguchi; S R Husain; R J Kreitman; I Pastan; R K Puri
Journal:  Mol Med       Date:  2000-03       Impact factor: 6.376

View more
  31 in total

1.  Analysis of tumor-infiltrating gamma delta T cells in rectal cancer.

Authors:  Liang Rong; Ke Li; Rui Li; Hui-Min Liu; Rui Sun; Xiao-Yan Liu
Journal:  World J Gastroenterol       Date:  2016-04-07       Impact factor: 5.742

2.  Profiling the pattern of the human T-cell receptor γδ complementary determinant region 3 repertoire in patients with lung carcinoma via high-throughput sequencing analysis.

Authors:  Hui Chen; Mingjin Zou; Da Teng; Yu Hu; Jianmin Zhang; Wei He
Journal:  Cell Mol Immunol       Date:  2018-02-05       Impact factor: 11.530

3.  miR-125b-5p and miR-99a-5p downregulate human γδ T-cell activation and cytotoxicity.

Authors:  Yuli Zhu; Siya Zhang; Zinan Li; Huaishan Wang; Zhen Li; Yu Hu; Hui Chen; Xuan Zhang; Lianxian Cui; Jianmin Zhang; Wei He
Journal:  Cell Mol Immunol       Date:  2018-02-12       Impact factor: 11.530

Review 4.  Regulatory functions of γδ T cells.

Authors:  Christian Peters; Dieter Kabelitz; Daniela Wesch
Journal:  Cell Mol Life Sci       Date:  2018-03-08       Impact factor: 9.261

5.  Human regulatory γδT cells and their functional plasticity in the tumor microenvironment.

Authors:  Hui Chen; Wei He
Journal:  Cell Mol Immunol       Date:  2017-08-28       Impact factor: 11.530

Review 6.  γδ T Cells: Unexpected Regulators of Cancer Development and Progression.

Authors:  Christopher Fleming; Samantha Morrissey; Yihua Cai; Jun Yan
Journal:  Trends Cancer       Date:  2017-07-17

Review 7.  Induced pluripotent stem cell-derived natural killer cells gene-modified to express chimeric antigen receptor-targeting solid tumors.

Authors:  Tatsuki Ueda; Shin Kaneko
Journal:  Int J Hematol       Date:  2020-07-23       Impact factor: 2.490

8.  STAT6 Signaling Attenuates Interleukin-17-Producing γδ T Cells during Acute Klebsiella pneumoniae Infection.

Authors:  Melissa H Bloodworth; Dawn C Newcomb; Daniel E Dulek; Matthew T Stier; Jacqueline Y Cephus; Jian Zhang; Kasia Goleniewska; Jay K Kolls; R Stokes Peebles
Journal:  Infect Immun       Date:  2016-04-22       Impact factor: 3.441

Review 9.  Chimeric antigen receptor (CAR)-transduced natural killer cells in tumor immunotherapy.

Authors:  Yuan Hu; Zhi-Gang Tian; Cai Zhang
Journal:  Acta Pharmacol Sin       Date:  2017-09-07       Impact factor: 6.150

Review 10.  γδ T cells: pleiotropic immune effectors with therapeutic potential in cancer.

Authors:  Bruno Silva-Santos; Sofia Mensurado; Seth B Coffelt
Journal:  Nat Rev Cancer       Date:  2019-07       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.